Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Pyrhonen, S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 80 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Barkardottir, RB; Sarantaus, L; Arason, A; Vehmanen, P; Bendahl, PO; Kainu, T; Syrjakoski, K; Krahe, R; Huusko, P; Pyrhonen, S; Holli, K; Kallioniemi, OP; Egilsson, V; Kere, J; Nevanlinna, H
      Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families

      EUROPEAN JOURNAL OF HUMAN GENETICS
    2. Nikkola, J; Vihinen, P; Vlaykova, T; Hahka-Kemppinen, M; Kahari, VM; Pyrhonen, S
      High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma

      MELANOMA RESEARCH
    3. Eerola, H; Pukkala, E; Pyrhonen, S; Blomqvist, C; Sankila, R; Nevanlinna, H
      Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)

      CANCER CAUSES & CONTROL
    4. Marttunen, MB; Hietanen, P; Pyrhonen, S; Tiitinen, A; Ylikorkala, O
      A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy

      MATURITAS
    5. Eerola, H; Vahteristo, P; Sarantaus, L; Kyyronen, P; Pyrhonen, S; Blomqvist, C; Pukkala, E; Nevanlinna, H; Sankila, R
      Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breastcancer families: A relative survival analysis from Finland

      INTERNATIONAL JOURNAL OF CANCER
    6. Kankuri, M; Pelliniemi, TT; Pyrhonen, S; Nikkanen, V; Helenius, H; Salminen, E
      Feasibility of prolonged use of interferon-alpha in metastatic kidney carcinoma - A phase II study

      CANCER
    7. Marttunen, MB; Cacciatore, B; Hietanen, P; Pyrhonen, S; Tiitinen, A; Wahlstrom, T; Ylikorkala, O
      Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women

      BRITISH JOURNAL OF CANCER
    8. Sauroja, I; Smeds, J; Vlaykova, T; Kumar, R; Talve, L; Hahka-Kemppinen, M; Punnonen, K; Jansen, CT; Hemminki, K; Pyrhonen, S
      Analysis of G(1)/S checkpoint regulators in metastatic melanoma

      GENES CHROMOSOMES & CANCER
    9. Vihinen, P; Nikkola, J; Vlaykova, T; Hahka-Kemppinen, M; Talve, L; Heino, J; Pyrhonen, S
      Prognostic value of beta 1 integrin expression in metastatic melanoma

      MELANOMA RESEARCH
    10. Eerola, H; Blomqvist, C; Pukkala, E; Pyrhonen, S; Nevanlinna, H
      Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?

      EUROPEAN JOURNAL OF CANCER
    11. Ruotsalainen, T; Halme, M; Isokangas, OP; Pyrhonen, S; Mantyla, M; Pekonen, M; Sarna, S; Joensuu, H; Mattson, K
      Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer - a feasibility study

      ANTI-CANCER DRUGS
    12. Eskelin, S; Pyrhonen, S; Summanen, P; Hahka-Kemppinen, M; Kivela, T
      Tumor doubling times in metastatic malignant melanoma of the uvea - Tumor progression before and after treatment

      OPHTHALMOLOGY
    13. Kainu, T; Juo, SHH; Desper, R; Schaffer, AA; Gillanders, E; Rozenblum, E; Freas-Lutz, D; Weaver, D; Stephan, D; Bailey-Wilson, J; Kallioniemi, OP; Tirkkonen, M; Syrjakoski, K; Kuukasjarvi, T; Koivisto, P; Karhu, R; Holli, K; Arason, A; Johannesdottir, G; Bergthorsson, JT; Johannsdottir, H; Egilsson, V; Barkardottir, RB; Johannsson, O; Haraldsson, K; Sandberg, T; Holmberg, E; Gronberg, H; Olsson, H; Borg, A; Vehmanen, P; Eerola, H; Heikkila, P; Pyrhonen, S; Nevanlinna, H
      Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    14. Hernberg, M; Pyrhonen, S; Muhonen, T
      Regimens with or without interferon-alpha as treatment for metastatic melanoma and renal cell carcinoma: An overview of randomized trials

      JOURNAL OF IMMUNOTHERAPY
    15. Ruotsalainen, TM; Halme, M; Tamminen, K; Szopinski, JN; Niiranen, A; Pyrhonen, S; Riska, H; Maasilta, P; Jekunen, A; Mantyla, M; Kajanti, M; Joensuu, H; Sarna, S; Cantell, K; Mattson, K
      Concomitant chemotherapy and IFN-alpha for small cell lung cancer: A randomized multicenter phase III study

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    16. Ilmonen, S; Kariniemi, AL; Vlaykova, T; Muhonen, T; Pyrhonen, S; Asko-Seljavaara, S
      Prognostic value of tumour vascularity in primary melanoma

      MELANOMA RESEARCH
    17. Vlaykova, T; Laurila, P; Muhonen, T; Hahka-Kemppinen, M; Jekunen, A; Alitalo, K; Pyrhonen, S
      Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression

      MELANOMA RESEARCH
    18. Pyrhonen, S; Salminen, E; Ruutu, M; Lehtonen, T; Nurmi, M; Tammela, T; Juusela, H; Rintala, E; Hietanen, P; Kellokumpu-Lehtinen, PL
      Prospective randomized trial of interferon alfa-2a plus vinblastine versusvinblastine alone in patients with advanced renal cell cancer

      JOURNAL OF CLINICAL ONCOLOGY
    19. Eerola, H; Blomqvist, C; Pyrhonen, S; Nevanlinna, H
      Familial breast cancer in Southern Finland

      DISEASE MARKERS
    20. Pyrhonen, S; Ellmen, J; Vuorinen, J; Gershanovich, M; Tominaga, T; Kaufmann, M; Hayes, DF
      Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    21. Vlaykova, T; Talve, L; Hahka-Kemppinen, M; Hernberg, M; Muhonen, T; Franssila, K; Collan, Y; Pyrhonen, S
      MIB-1 immunoreactivity correlates with blood vessel density and survival in disseminated malignant melanoma

      ONCOLOGY
    22. Eskelin, S; Pyrhonen, S; Summanen, P; Prause, JU; Kivela, T
      Screening for metastatic malignant melanoma of the uvea revisited

      CANCER
    23. HERNBERG M; TURUNEN JP; VONBOGUSLAWSKY K; MUHONEN T; PYRHONEN S
      PROGNOSTIC VALUE OF BIOMARKERS IN MALIGNANT-MELANOMA

      Melanoma research
    24. PYRHONEN S
      THE TREATMENT OF METASTATIC UVEAL MELANOMA

      European journal of cancer
    25. CUNNINGHAM D; PYRHONEN S; JAMES RD; PUNT CJA; HICKISH TF; HEIKKILA R; JOHANNESEN TB; STARKHAMMAR H; TOPHAM CA; AWAD L; JACQUES C; HERAIT P
      RANDOMIZED TRIAL OF IRINOTECAN PLUS SUPPORTIVE CARE VERSUS SUPPORTIVECARE ALONE AFTER FLUOROURACIL FAILURE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER

      Lancet
    26. HERNBERG M; TURUNEN JP; MUHONEN T; PYRHONEN S
      TUMOR-INFILTRATING LYMPHOCYTES IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY

      Journal of immunotherapy
    27. MEURMAN JH; PYRHONEN S; TEERENHOVI L; LINDQVIST C
      ORAL SOURCES OF SEPTICEMIA IN PATIENTS WITH MALIGNANCIES

      Oral Oncology
    28. MEURMAN JH; LAINE P; LINDQVIST C; TEERENHOVI L; PYRHONEN S
      5-YEAR FOLLOW-UP-STUDY OF SALIVA, MUTANS STREPTOCOCCI, LACTOBACILLI AND YEAST COUNTS IN LYMPHOMA PATIENTS

      Oral Oncology
    29. MATTSON K; NIIRANEN A; RUOTSALAINEN T; MAASILTA P; HALME M; PYRHONEN S; KAJANTI M; MANTYLA M; TAMMINEN K; JEKUNEN A; SARNA S; CANTELL K
      INTERFERON MAINTENANCE THERAPY FOR SMALL-CELL LUNG-CANCER - IMPROVEMENT IN LONG-TERM SURVIVAL

      Journal of interferon & cytokine research
    30. MEURMAN JH; LAINE P; KEINANEN S; PYRHONEN S; TEERENHOVI L; LINDQVIST C
      5-YEAR FOLLOW-UP OF SALIVA IN PATIENTS TREATED FOR LYMPHOMAS

      Oral surgery, oral medicine, oral pathology, oral radiology and endodontics
    31. VEHMANEN P; FRIEDMAN LS; EEROLA H; MCCLURE M; WARD B; SARANTAUS L; KAINU T; SYRJAKOSKI K; PYRHONEN S; KALLIONIEMI OP; MUHONEN T; LUCE M; FRANK TS; NEVANLINNA H
      LOW PROPORTION OF BRCA1 AND BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES - EVIDENCE FOR ADDITIONAL SUSCEPTIBILITY GENES

      Human molecular genetics
    32. HAHKAKEMPPINEN M; MUHONEN T; NORDLING S; PYRHONEN S
      DNA FLOW-CYTOMETRY AND THE OUTCOME OF CHEMOIMMUNOTHERAPY IN METASTATIC MELANOMA

      Melanoma research
    33. HERNBERG M; MUHONEN T; PYRHONEN S
      CAN THE CD4+ CD8+ RATIO PREDICT THE OUTCOME OF INTERFERON-ALPHA THERAPY FOR RENAL-CELL CARCINOMA/

      Annals of oncology
    34. HOLSTI LR; PYRHONEN S; KAJANTI M; MANTYLA M; MATTSON K; MAASILTA P; KIVISAARI L
      ALTERED FRACTIONATION OF HEMITHORAX IRRADIATION FOR PLEURAL MESOTHELIOMA AND FAILURE PATTERNS AFTER TREATMENT

      Acta oncologica
    35. SHATTUCKEIDENS D; OLIPHANT A; MCCLURE M; MCBRIDE C; GUPTE J; RUBANO T; PRUSS D; TAVTIGIAN SV; TENG DHF; ADEY N; STAEBELL M; GUMPPER K; LUNDSTROM R; HULICK M; KELLY M; HOLMEN J; LINGENFELTER B; MANLEY S; FUJIMURA F; LUCE M; WARD B; CANNONALBRIGHT L; STEELE L; OFFIT K; GILEWSKI T; NORTON L; BROWN K; SCHULZ C; HAMPEL H; SCHLUGER A; GIULOTTO E; ZOLI W; RAVAIOLI A; NEVANLINNA H; PYRHONEN S; ROWLEY P; LOADER S; OSBORNE MP; DALY M; TEPLER I; WEINSTEIN PL; SCALIA JL; MICHAELSON R; SCOTT RJ; RADICE P; PIEROTTI MA; GARBER JE; ISAACS C; PESHKIN B; LIPPMAN ME; DOSIK MH; CALIGO MA; GREENSTEIN RM; PILARSKI R; WEBER B; BURGEMEISTER R; FRANK TS; SKOLNICK MH; THOMAS A
      BRCA-1 SEQUENCE-ANALYSIS IN WOMEN AT HIGH-RISK FOR SUSCEPTIBILITY MUTATIONS - RISK FACTOR-ANALYSIS AND IMPLICATIONS FOR GENETIC TESTING

      JAMA, the journal of the American Medical Association
    36. VLAYKOVA T; JEKUNEN AP; KESOMAA M; KAIREMO KJA; PYRHONEN S; WASENIUS VM
      INCREASED THYMIDYLATE SYNTHASE GENE-EXPRESSION IN METASTATIC MELANOMA

      Oncology
    37. VLAYKOVA T; MUHONEN T; HAHKAKEMPPINEN M; PYRHONEN S; JEKUNEN A
      VASCULARITY AND PROGNOSIS OF METASTATIC MELANOMA

      International journal of cancer
    38. MAICHE AG; PYRHONEN S
      VERRUCOUS CARCINOMA OF THE PENIS - 3 CASES TREATED WITH INTERFERON-ALPHA

      British Journal of Urology
    39. MUHONEN T; EEROLA H; VEHMANEN P; NEVANLINNA H; AKTAN K; BLOMQVIST C; KAARIAINEN H; PYRHONEN S
      BREAST-CANCER RISK-ESTIMATION IN FAMILIES WITH HISTORY OF BREAST-CANCER

      British Journal of Cancer
    40. PYRHONEN S; VALAVAARA R; MODIG H; PAWLICKI M; PIENKOWSKI T; GUNDERSEN S; BAUER J; WESTMAN G; LUNDGREN S; BIANCO G; MELLA O; NILSSON I; HIETANEN T; HINDY I; VUORINEN J; HAJBA A
      COMPARISON OF TOREMIFENE AND TAMOXIFEN IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - A RANDOMIZED DOUBLE-BLIND, THE NORDIC PHASE-III STUDY

      British Journal of Cancer
    41. KAINU T; TIRKKONEN M; KONONEN J; JOHANSSON O; LOMAN N; OLSSON H; SYRJAKOSKI K; EEROLA HL; HEIKKILA P; PYRHONEN S; AGNARSSON BA; EGILSSON V; BARKARDOTTIR R; NEVANLINNA H; BORG A; KALLIONIEMI OP
      SOMATIC GENETIC AND PHENOTYPIC CHARACTERISTICS OF HEREDITARY BREAST-CANCER

      American journal of human genetics
    42. VEHMANEN P; FRIEDMAN LS; EEROLA H; MCCLURE M; WARD B; SARANTAUS L; KAINU T; SYRJAKOSKI K; PYRHONEN S; KALLIONIEMI OP; MUHONEN T; LUCE M; FRANK TS; NEVANLINNA HA
      A LAW PROPORTION OF BRCA1 AND BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES - STRONG EVIDENCE FOR ADDITIONAL SUSCEPTIBILITY GENES

      American journal of human genetics
    43. VEHMANEN P; FRIEDMAN LS; EEROLA H; SARANTAUS L; PYRHONEN S; PONDER BAJ; MUHONEN T; NEVANLINNA H
      A LOW PROPORTION OF BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES

      American journal of human genetics
    44. HAHKAKEMPPINEN M; MUHONEN T; KANGAS L; PYRHONEN S
      CHEMOSENSITIVITY OF HUMAN-MELANOMA METASTASES IN MOUSE SUBRENAL CAPSULE ASSAY - CAN IT PREDICT TUMOR RESPONSE TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY IN METASTATIC MELANOMA

      Melanoma research
    45. SAARINEN A; JEKUNEN A; HALME M; PYRHONEN S; TAMMINEN K; BOYER R; ROUBILLE N; MATTSON K
      A PHASE-II TRIAL OF DOCETAXEL IN ADVANCED NONSMALL CELL LUNG-CANCER

      Anti-cancer drugs
    46. VILLIKKA K; PYRHONEN S
      CYTOKINE THERAPY OF MALIGNANT-MELANOMA

      Annals of medicine
    47. GYLLING H; PYRHONEN S; MAENPAA H; MIETTINEN TA; MANTYLA E; KANGAS L
      ANTIESTROGENS AND THE REDUCTION IN CIRCULATING CHOLESTEROL - IN REPLY

      Journal of clinical oncology
    48. HERNBERG M; MUHONEN T; TURUNEN JP; HAHKAKEMPPINEN M; PYRHONEN S
      THE CD4+ CD8+ RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY/

      Journal of clinical oncology
    49. JARVINEN LS; PYRHONEN S; KAIREMO KJA; PAAVONEN T
      THE EFFECT OF ANTIESTROGENS ON CYTOKINE PRODUCTION IN-VITRO

      Scandinavian journal of immunology
    50. HAKKINEN AM; LAASONEN A; LINNAINMAA K; MATTSON K; PYRHONEN S
      RADIOSENSITIVITY OF MESOTHELIOMA CELL-LINES

      Acta oncologica
    51. JEKUNEN A; PYRHONEN S
      A COMBINATION OF VINBLASTINE AND DOXORUBICIN WITH INTERFERON-ALPHA

      American journal of clinical oncology
    52. MUHONEN T; JANTUNEN I; PERTOVAARA H; VOUTILAINEN L; MAICHE A; BLOMQVIST C; PYRHONEN S; KELLOKUMPULEHTINEN P
      PROPHYLACTIC FILGRASTIM (G-CSF) DURING MITOMYCIN-C, MITOXANTRONE, ANDMETHOTREXATE (MMT) TREATMENT FOR METASTATIC BREAST-CANCER - A RANDOMIZED STUDY

      American journal of clinical oncology
    53. ISOKANGAS OP; MUHONEN T; KAJANTI M; PYRHONEN S
      RADIATION-THERAPY OF INTRACRANIAL MALIGNANT-MELANOMA

      Radiotherapy and oncology
    54. MARTTUNEN MB; PYRHONEN S; TIITINEN AE; VIINIKKA LU; YLIKORKALA O
      EFFECT OF ANTIESTROGEN REGIMEN ON PROSTACYCLIN AND THROMBOXANE A(2) IN POSTMENOPAUSAL PATIENTS WITH BREAST-CANCER - EVIDENCE OF SIGNIFICANCE OF HYPERTENSION, SMOKING OR PREVIOUS USE OF ESTROGEN THERAPY

      Prostaglandins
    55. MEURMAN JH; LAINE P; LINDQVIST C; PYRHONEN S
      EFFECT OF IV-INFUSION ON SALIVARY FLOW IN LYMPHOMA PATIENTS

      Journal of dental research
    56. ALBERTI W; ANDERSON G; BARTOLUCCI A; BELL D; VILLALBA JB; BRODIN O; CARDIELLO C; CARTEI F; CARTEI G; CELLERINO R; CHASTANG C; CORMIER Y; COX JD; CRINO L; CROWLEY J; DAUTZENBERG B; DEPIERRE A; DIETEMANN A; DILLMAN RO; DOI O; FELD R; FIGLIN R; GANZ PA; GREEN MR; GREGOR A; HELLE PA; HERNDON JE; HITOMI S; HOST H; IMAIZUMI M; JETT JR; JOHNSON D; KAASA S; KIMURA H; KLASTERSKY J; KONDO H; KREISMAN H; KRIS MG; KUNISHIMA K; KUWAHARA O; LAD TE; LAING AH; MACBETH F; MASAOKA A; MATTSON K; MINATEL E; MIRA JG; MORI T; MOUNTAIN CF; NIEDERLE N; NIIRANEN A; NOU E; PAGE W; PATER J; PIANTADOSI S; PISTERS KMW; PYRHONEN S; QUOIX E; RAPP E; ROWELL NP; SAHMOUD T; SAWAMURA K; SCHALLIER DCC; SCOTT C; SIMPSON J; STAGG M; TERAMATSU T; TROVO MG; TSUCHIYA R; TUMMARELLO D; VANHOUTTE P; VANZANDWIJK N; VINCENT RG; WADA H; WHITE JE; WILLIAMS CJ; WOODS RL; YAMAGUCHI Y; ARRIAGADA R; CARTMELLDAVIES J; GIRLING DJ; LECHEVALIER T; MARSONI S; PARMAR MKB; PIGNON JP; REKACEWICZ C; SOUHAMI RL; STEWART LA; TARAYRE M; TINAZZI A; TONI V
      CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS

      BMJ. British medical journal
    57. MANTYLA E; GYLLING H; KANGAS L; PYRHONEN S; MAENPAA H; VALAVAARA R; MIETTINEN T
      TAMOXIFEN AND TOREMIFENE - THE BENEFICIAL HYPOLIPEMIC EFFECT IN WOMENIS MEDIATED BY CHOLESTEROL-BIOSYNTHESIS INHIBITION

      European journal of cancer
    58. KESOMAA M; JEKUNEN A; VLAYKOVA T; WASENIUS VM; KAIREMO KJA; PYRHONEN S
      INCREASED THYMIDYLATE SYNTHASE GENE-EXPRESSION IN METASTATIC MELANOMA

      European journal of cancer
    59. DALLEY D; LEVI J; BELL D; GREEN M; SHERMAN P; ZALCBERG J; ZIMET A; THOMSON D; WALPOLE E; ACKLAND S; STEWART J; SCHULLER J; FOGL U; WIRTH M; LUTZ D; SALOMON J; VANTRAPPEN G; VANCUTSEM E; LEPOUTRE L; DEFACQ L; BURY J; REGINSTER M; FROIMTCHUK M; DEOLIVEIRA MDLL; SCALETZKY A; KOCHA W; SKILLINGS J; WEINERMAN B; SHORE T; MAROUN J; CRIPPS C; GOEL R; BATIST G; BOOS G; GADEBERG C; KJAER M; BRUNSGAARD N; JAKOBSEN A; MEJLHOLM J; BERTELSEN K; MADSEN EL; JORGENSEN A; SANDBERG E; PYRHONEN S; ISOKANGAS OP; JOHANSSON R; KATAJA V; ROUGIER P; BECOUARN Y; BRUNET R; FRANCOIS E; NAMER M; SEITZ J; GIOVANNINI H; REBATTU P; MERROUCHE Y; LANKISCH P; HEISE J; MAY B; GREVING J; SODOMANN C; BERGERMANN H; MERTELSMANN R; SCHUPP M; PORZSOLT F; STEINACKER RM; CARTEI G; BAJETTA E; COLLEONI M; PANNUTI E; FOSSER V; BERG C; RAVN H; EGELI R; GUILLOU P; SOMERS S; CAREY P; PRIMROSE J; SELBY P; WARD U; BUDDE M; HOLDENER EE; MAN A; MASSIMINI G; SMITH H; LUYKX R; BLAES C; YAP AKL; HOLMSTROM S; COCKEY L
      PHASE-III RANDOMIZED STUDY OF 2 FLUOROURACIL COMBINATIONS WITH EITHERINTERFERON-ALFA-2A OR LEUCOVORIN FOR ADVANCED COLORECTAL-CANCER

      Journal of clinical oncology
    60. GYLLING H; PYRHONEN S; MANTYLA E; MAENPAA H; KANGAS L; MIETTINEN TA
      TAMOXIFEN AND TOREMIFENE LOWER SERUM-CHOLESTEROL BY INHIBITION OF DELTA(8)-CHOLESTENOL CONVERSION TO LATHOSTEROL IN WOMEN WITH BREAST-CANCER

      Journal of clinical oncology
    61. SALMINEN E; PUKKALA E; TEPPO L; PYRHONEN S
      RISK OF 2ND CANCERS AMONG LUNG-CANCER PATIENTS

      Acta oncologica
    62. HAHKAKEMPPINEN M; MUHONEN T; VIROLAINEN M; JEKUNEN A; ASKOSELJAVAARA S; PYRHONEN S
      RESPONSE OF SUBCUTANEOUS AND CUTANEOUS METASTASES OF MALIGNANT-MELANOMA TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY

      British journal of dermatology
    63. PYRHONEN S; KUITUNEN T; NYANDOTO P; KOURI M
      RANDOMIZED COMPARISON OF FLUOROURACIL, EPIDOXORUBICIN AND METHOTREXATE (FEMTX) PLUS SUPPORTIVE CARE WITH SUPPORTIVE CARE ALONE IN PATIENTS WITH NONRESECTABLE GASTRIC-CANCER

      British Journal of Cancer
    64. MUHONEN T; HAHKAKEMPPINEN M; PAKKALA S; PYRHONEN S
      DECREASING CD4 CD8 RATIO DURING PROLONGED 4-DRUG CHEMOTHERAPY PLUS INTERFERON TREATMENT FOR METASTATIC MELANOMA/

      Journal of immunotherapy with emphasis on tumor immunology
    65. MEURMAN JH; LAINE P; LINDQVIST C; PYRHONEN S; TEERENHOVI L
      EFFECT OF ANTICANCER DRUGS ON PATIENTS WITH AND WITHOUT INITIALLY REDUCED SALIVA FLOW

      European journal of cancer. Part B, Oral oncology
    66. VUORISTO M; JANTUNEN I; PYRHONEN S; MUHONEN T; KELLOKUMPULEHTINEN P
      A COMBINATION OF SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA IN THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA OR MELANOMA

      European journal of cancer
    67. SALMINEN E; PUKKALA E; TEPPO L; PYRHONEN S
      SUBSEQUENT PRIMARY CANCERS FOLLOWING BLADDER-CANCER

      European journal of cancer
    68. JEKUNEN A; STENGARD J; PYRHONEN S
      PHASE-II STUDY OF VINBLASTINE AND DOXORUBICIN IN ADVANCED RENAL-CELL CARCINOMA

      European journal of cancer
    69. PORKKA K; BLOMQVIST C; RISSANEN P; ELOMAA I; PYRHONEN S
      SALVAGE THERAPIES IN WOMEN WHO FAIL TO RESPOND TO FIRST-LINE TREATMENT WITH FLUOROURACIL, EPIRUBICIN, AND CYCLOPHOSPHAMIDE FOR ADVANCED BREAST-CANCER

      Journal of clinical oncology
    70. MUHONEN T; PYRHONEN S; LAASONEN A; WASENIUS VM; ASKOSELJAVAARA S; FRANSSILA K; KANGAS L
      MOUSE SUBRENAL CAPSULE ASSAY CHEMOSENSITIVITY AND DNA FLOW-CYTOMETRY PARAMETERS OF HUMAN-MELANOMA METASTASES

      Acta oncologica
    71. KAJANTI M; PYRHONEN S
      EPIRUBICIN-SEQUENTIAL METHOTREXATE-5-FLUOROURACIL-LEUCOVORIN TREATMENT IN ADVANCED CANCER OF THE EXTRAHEPATIC BILIARY SYSTEM - A PHASE-II STUDY

      American journal of clinical oncology
    72. PYRHONEN S; VALAVAARA R; VUORINEN J; HAJBA A
      HIGH-DOSE TOREMIFENE IN ADVANCED BREAST-CANCER RESISTANT TO OR RELAPSED DURING TAMOXIFEN TREATMENT

      Breast cancer research and treatment
    73. JEKUNEN A; HEIKKILA P; MAICHE A; PYRHONEN S
      PACLITAXEL-INDUCED MYOCARDIAL DAMAGE DETECTED BY ELECTRON-MICROSCOPY

      Lancet
    74. KAIPAINEN A; VLAYKOVA T; HATVA E; BOHLING T; JEKUNEN A; PYRHONEN S; ALITALO K
      ENHANCED EXPRESSION OF THE TIE RECEPTOR TYROSINE KINASE MESSENGER-RNAIN THE VASCULAR ENDOTHELIUM OF METASTATIC MELANOMAS

      Cancer research
    75. CROPP CS; NEVANLINNA HA; PYRHONEN S; STENMAN U; SALMIKANGAS P; ALBERTSEN B; WHITE R; CALLAHAN R
      EVIDENCE FOR INVOLVEMENT OF BRCA1 IN SPORADIC BREAST CARCINOMAS

      Cancer research
    76. KOURI M; NORDLING S; KUUSELA P; PYRHONEN S
      POOR-PROGNOSIS ASSOCIATED WITH ELEVATED SERUM CA 19-9 LEVEL IN ADVANCED COLORECTAL-CARCINOMA, INDEPENDENT OF DNA-PLOIDY OR SPF

      European journal of cancer
    77. LAINE P; MEURMAN JH; MURTOMAA H; LINDQVIST C; TORKKO H; PYRHONEN S; TEERENHOVI L
      ONE-YEAR TRIAL OF THE EFFECT OF RINSING WITH AN AMINE FLUORIDE-STANNOUS-FLUORIDE-CONTAINING MOUTHWASH ON GINGIVAL INDEX SCORES AND SALIVARYMICROBIAL COUNTS IN LYMPHOMA PATIENTS RECEIVING CYTOSTATIC DRUGS

      Journal of clinical periodontology
    78. LIEWENDAHL K; PYRHONEN S
      RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY OF MALIGNANT-MELANOMA - AREVIEW

      Acta oncologica
    79. JAAKKOLA S; SALMIKANGAS P; NYLUND S; PARTANEN J; ARMSTRONG E; PYRHONEN S; LEHTOVIRTA P; NEVANLINNA H
      AMPLIFICATION OF FGFR4 GENE IN HUMAN BREAST AND GYNECOLOGICAL CANCERS

      International journal of cancer
    80. MATTSON K; MAASILTA P; HALME M; NIIRANEN A; PYRHONEN S; RISKA H; CANTELL K; EKLUND J
      CHEMOTHERAPY PLUS ALPHA-INTERFERON IN THE TREATMENT OF SMALL-CELL LUNG-CANCER - A RANDOMIZED PHASE-III STUDY

      The American review of respiratory disease


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 08:57:07